Skip to content

Epizyme, Inc.

Delisted

CIK 1571498fmd_1Q1RTCHX2BAC58ZDNP4EKT6NEAManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2011 to Jun 30, 2022, 43 periods

Latest annual · FY2021

Millions
Total revenues
37
Gross profit
27
Operating income
(238)
Net income
(251)
Free cash flow
(227)

Latest quarter · Q2 FY2022

Millions
Total revenues
28
Gross profit
22
Operating income
(30)
Net income
(36)
Free cash flow
(55)
Open Financials

Key stats

Open Analysis

Compound annual growth

Revenue, 3 yearsFY2018 to FY2021
+19.9%
Revenue, 5 yearsFY2016 to FY2021
+36.1%
Net income, 5 yearsFY2016 to FY2021
n/m

Epizyme, Inc. financials: quick answers

Annual figures as filed with the SEC. Each number links to the filing it came from and to its proof.

MetricFY2021FY2020ChangeSource
Revenue$37.4 million$15.8 million+137.5%10-K 2022-03-01 · proof
Gross profit$26.9 million$10.7 million+151.8%10-K 2022-03-01 · proof
Operating income-$238 million-$225.4 million10-K 2022-03-01 · proof
Net income-$251.1 million-$231.7 million10-K 2022-03-01 · proof
Cash from operating activities-$226.9 million-$206.3 million10-K 2022-03-01 · proof
Free cash flow-$227.3 million-$207.2 million10-K 2022-03-01 · proof
Total assets$289 million$473.6 million-39%10-K 2022-03-01 · proof
Total liabilities$309.7 million$288.7 million+7.3%10-K 2022-03-01 · proof
Cash and cash equivalents$98.3 million$168.2 million-41.5%10-K 2022-03-01 · proof
Total debt$216.5 million$215.7 million+0.4%10-K 2022-03-01 · proof
What was Epizyme, Inc.'s revenue in fiscal 2021?
Epizyme, Inc. reported revenue of $37.4 million for fiscal 2021 (the year ended Dec 31, 2021), against $15.8 million the year before (+137.5%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was Epizyme, Inc.'s gross profit in fiscal 2021?
Epizyme, Inc. reported gross profit of $26.9 million for fiscal 2021 (the year ended Dec 31, 2021), against $10.7 million the year before (+151.8%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was Epizyme, Inc.'s operating income in fiscal 2021?
Epizyme, Inc. reported operating income of -$238 million for fiscal 2021 (the year ended Dec 31, 2021), against -$225.4 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was Epizyme, Inc.'s net income in fiscal 2021?
Epizyme, Inc. reported net income of -$251.1 million for fiscal 2021 (the year ended Dec 31, 2021), against -$231.7 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was Epizyme, Inc.'s cash from operating activities in fiscal 2021?
Epizyme, Inc. reported cash from operating activities of -$226.9 million for fiscal 2021 (the year ended Dec 31, 2021), against -$206.3 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What was Epizyme, Inc.'s free cash flow in fiscal 2021?
Epizyme, Inc. reported free cash flow of -$227.3 million for fiscal 2021 (the year ended Dec 31, 2021), against -$207.2 million the year before. Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What are Epizyme, Inc.'s total assets?
As of Dec 31, 2021, Epizyme, Inc. reported total assets of $289 million, against $473.6 million a year earlier (-39%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What are Epizyme, Inc.'s total liabilities?
As of Dec 31, 2021, Epizyme, Inc. reported total liabilities of $309.7 million, against $288.7 million a year earlier (+7.3%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What are Epizyme, Inc.'s cash and cash equivalents?
As of Dec 31, 2021, Epizyme, Inc. reported cash and cash equivalents of $98.3 million, against $168.2 million a year earlier (-41.5%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC
What is Epizyme, Inc.'s total debt?
As of Dec 31, 2021, Epizyme, Inc. reported total debt of $216.5 million, against $215.7 million a year earlier (+0.4%). Source: the 10-K filed with the SEC on Mar 1, 2022. SEC

Read from the FinancialMD API on Nov 13, 2026. Values change only when a new filing is made; see the Financials tab for every period and as-of replay.

The same numbers for an agent, with proof on every value:

curl "https://api.financial.md/v1/company/financials/income_statement/standardized?company=cik:1571498&period_type=annual&limit=5"

Information only, not investment advice.